New federal legislation would regulate an industry that’s been examined by FactFinder. Senator Jerry Moran, R-Kan., is one of ...
The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...
Because the Congressional Budget Office predicts some PBM legislation would reduce federal ... The previous bills would have instituted significant new transparency requirements on drug industry ...
Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high costs members may face. The PBM said in an announcement that about 80% ...